Seres Therapeutics, Inc. Gains 389.22%
Mon, Aug 10, 2020 at 05:34 PM
Seres Therapeutics, Inc. (MCRB:NASDAQ) rocketted at $22.7, representing a gain of 389.2%. On Fri 07 Aug 20, MCRB:NASDAQ hit a New 2-Week High of $4.64. The stock got featured on our News Catalysts scanner on Mon 10 Aug 20 at 02:29 PM in the 'BIOTECH' category. From Fri 24 Jul 20, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Wed 08 Jul 20 at $6.75 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Seres Therapeutics, Inc. (MCRB:NASDAQ)
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.
Top 10 Gainers:
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 389.22%
- Omeros Corporation (OMER:NASDAQ), 50.88%
- BiomX Inc. (PHGE:NYSEMKT), 42.1%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 37.04%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 32.43%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 31.75%
- Trevena, Inc. (TRVN:NASDAQ), 31.51%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 30.51%
- LSB Industries, Inc. (LXU:NYSE), 29.75%
- Ocugen, Inc. (OCGN:NASDAQ), 28.18%